AG
PRCT icon

AlTi Global’s Procept Biorobotics PRCT Stock Holding History

AlTi Global’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-59,844
Closed -$3.45M – 447
2025
Q2 		$3.45M Buy
59,844
+4
+0% +$226 0.09% 119
2025
Q1 		$3.49M Hold
59,840
– – 0.09% 105
2024
Q4 		$4.82M Hold
59,840
– – 0.12% 98
2024
Q3 		$4.79M Sell
59,840
-6,106
-9% -$434K 0.12% 103
2024
Q2 		$4.03M Hold
65,946
– – 0.11% 98
2024
Q1 		$3.26M Hold
65,946
– – 0.09% 109
2023
Q4 		$2.76M Buy
+65,946
New +$2.25M 0.08% 104

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AlTi Global's PRCT Position: Q3 2025 in Review

AlTi Global sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 59,844 shares — an estimated $3.45M sold.

AlTi Global first reported a position in PRCT in Q4 2023 and held it in 7 quarters. The position peaked at $4.82M in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • AlTi Global reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • AlTi Global sold 59,844 Procept Biorobotics shares in Q3 2025, an estimated $3.45M.
  • AlTi Global first reported a position in Procept Biorobotics in Q4 2023 and held it in 7 quarters.
  • AlTi Global's Procept Biorobotics position peaked at $4.82M in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on AlTi Global's 13F filing for Q3 2025, filed 6 Nov 2025.